Brief: BiomX Presents Preclinical Results With BX005 For Atopic Dermatitis

June 14 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX PRESENTS PRECLINICAL RESULTS WITH BX005 FOR ATOPIC
DERMATITIS AT THE REVOLUTIONIZING ATOPIC DERMATITIS 2021 VIRTUAL
CONFERENCE AND THE INTERNATIONAL CONFERENCE ON PHAGE THERAPY AND
BACTERIOPHAGES

Source text for Eikon:  ID:nBw4NXb6ka 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biomx

See all news